These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26987717)

  • 21. Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.
    Openshaw RL; Thomson DM; Penninger JM; Pratt JA; Morris BJ
    Psychopharmacology (Berl); 2017 Jan; 234(2):293-305. PubMed ID: 27774567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
    Hudson AM; Stephenson NL; Li C; Trotter E; Fletcher AJ; Katona G; Bieniasz-Krzywiec P; Howell M; Wirth C; Furney S; Miller CJ; Brognard J
    Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
    Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverse physiological functions of MKK4 and MKK7 during early embryogenesis.
    Asaoka Y; Nishina H
    J Biochem; 2010 Oct; 148(4):393-401. PubMed ID: 20801953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights.
    Cherry M; Williams DH
    Curr Med Chem; 2004 Mar; 11(6):663-73. PubMed ID: 15032722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.
    Schnieders MJ; Kaoud TS; Yan C; Dalby KN; Ren P
    Curr Pharm Des; 2012; 18(9):1173-85. PubMed ID: 22316156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.
    Schirmer A; Kennedy J; Murli S; Reid R; Santi DV
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4234-9. PubMed ID: 16537514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of the catalytic domain of human protein kinase associated with apoptosis and tumor suppression.
    Tereshko V; Teplova M; Brunzelle J; Watterson DM; Egli M
    Nat Struct Biol; 2001 Oct; 8(10):899-907. PubMed ID: 11573098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
    Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
    Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein.
    Smith KJ; Carter PS; Bridges A; Horrocks P; Lewis C; Pettman G; Clarke A; Brown M; Hughes J; Wilkinson M; Bax B; Reith A
    Structure; 2004 Jun; 12(6):1067-77. PubMed ID: 15274926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophosphorylation of Archaeoglobus fulgidus Rio2 and crystal structures of its nucleotide-metal ion complexes.
    LaRonde-LeBlanc N; Guszczynski T; Copeland T; Wlodawer A
    FEBS J; 2005 Jun; 272(11):2800-10. PubMed ID: 15943813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state.
    Matsumoto T; Kinoshita T; Kirii Y; Yokota K; Hamada K; Tada T
    Biochem Biophys Res Commun; 2010 Sep; 400(3):369-73. PubMed ID: 20732303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the C-terminal domain of the two-component system transmitter protein nitrogen regulator II (NRII; NtrB), regulator of nitrogen assimilation in Escherichia coli.
    Song Y; Peisach D; Pioszak AA; Xu Z; Ninfa AJ
    Biochemistry; 2004 Jun; 43(21):6670-8. PubMed ID: 15157101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
    Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.
    Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ
    Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for p38 protein kinase inhibitor specificity.
    Lisnock J; Tebben A; Frantz B; O'Neill EA; Croft G; O'Keefe SJ; Li B; Hacker C; de Laszlo S; Smith A; Libby B; Liverton N; Hermes J; LoGrasso P
    Biochemistry; 1998 Nov; 37(47):16573-81. PubMed ID: 9843424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma.
    Kumar A; Mandiyan V; Suzuki Y; Zhang C; Rice J; Tsai J; Artis DR; Ibrahim P; Bremer R
    J Mol Biol; 2005 Apr; 348(1):183-93. PubMed ID: 15808862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ensemble structural analyses depict the regulatory mechanism of non-phosphorylated human MAP2K4.
    Matsumoto T; Yamano A; Murakawa Y; Fukada H; Sawa M; Kinoshita T
    Biochem Biophys Res Commun; 2020 Jan; 521(1):106-112. PubMed ID: 31635803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural characterization of the active and inactive states of Src kinase in solution by small-angle X-ray scattering.
    Bernadó P; Pérez Y; Svergun DI; Pons M
    J Mol Biol; 2008 Feb; 376(2):492-505. PubMed ID: 18164031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
    Raaf J; Issinger OG; Niefind K
    J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.